121 related articles for article (PubMed ID: 35245730)
1. Tumor-specific nitric oxide generator to amplify peroxynitrite based on highly penetrable nanoparticles for metastasis inhibition and enhanced cancer therapy.
Shi M; Zhang J; Wang Y; Peng C; Hu H; Qiao M; Zhao X; Chen D
Biomaterials; 2022 Apr; 283():121448. PubMed ID: 35245730
[TBL] [Abstract][Full Text] [Related]
2. ICG/l-Arginine Encapsulated PLGA Nanoparticle-Thermosensitive Hydrogel Hybrid Delivery System for Cascade Cancer Photodynamic-NO Therapy with Promoted Collagen Depletion in Tumor Tissues.
Sun Z; Wang X; Liu J; Wang Z; Wang W; Kong D; Leng X
Mol Pharm; 2021 Mar; 18(3):928-939. PubMed ID: 33427470
[TBL] [Abstract][Full Text] [Related]
3. Stimuli-Responsive and Highly Penetrable Nanoparticles as a Multifunctional Nanoplatform for Boosting Nonsmall Cell Lung Cancer siRNA Therapy.
Shi M; Wang Y; Zhao X; Zhang J; Hu H; Qiao M; Zhao X; Chen D
ACS Biomater Sci Eng; 2021 Jul; 7(7):3141-3155. PubMed ID: 34137580
[TBL] [Abstract][Full Text] [Related]
4. Acidity-Triggered Tumor-Targeted Nanosystem for Synergistic Therapy via a Cascade of ROS Generation and NO Release.
Cao Y; Liu M; Cheng J; Yin J; Huang C; Cui H; Zhang X; Zhao G
ACS Appl Mater Interfaces; 2020 Jul; 12(26):28975-28984. PubMed ID: 32501667
[TBL] [Abstract][Full Text] [Related]
5. Blockage of the IDO1 pathway by charge-switchable nanoparticles amplifies immunogenic cell death for enhanced cancer immunotherapy.
Shi M; Zhang J; Wang Y; Han Y; Zhao X; Hu H; Qiao M; Chen D
Acta Biomater; 2022 Sep; 150():353-366. PubMed ID: 35843594
[TBL] [Abstract][Full Text] [Related]
6. Charge-reversal nanoparticles: novel targeted drug delivery carriers.
Chen X; Liu L; Jiang C
Acta Pharm Sin B; 2016 Jul; 6(4):261-7. PubMed ID: 27471667
[TBL] [Abstract][Full Text] [Related]
7. ATP Suppression by pH-Activated Mitochondria-Targeted Delivery of Nitric Oxide Nanoplatform for Drug Resistance Reversal and Metastasis Inhibition.
Deng Y; Jia F; Chen X; Jin Q; Ji J
Small; 2020 Jun; 16(23):e2001747. PubMed ID: 32378343
[TBL] [Abstract][Full Text] [Related]
8. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
9. TGF-β blockade-improved chemo-immunotherapy with pH/ROS cascade-responsive micelle via tumor microenvironment remodeling.
Dai L; Li X; Zheng X; Fu Z; Yao M; Meng S; Zhang J; Han B; Gao Q; Chang J; Cai K; Yang H
Biomaterials; 2021 Sep; 276():121010. PubMed ID: 34247042
[TBL] [Abstract][Full Text] [Related]
10. Dual pH/ROS-Responsive Nanoplatform with Deep Tumor Penetration and Self-Amplified Drug Release for Enhancing Tumor Chemotherapeutic Efficacy.
Li Y; Chen M; Yao B; Lu X; Song B; Vasilatos SN; Zhang X; Ren X; Yao C; Bian W; Sun L
Small; 2020 Aug; 16(32):e2002188. PubMed ID: 32627387
[TBL] [Abstract][Full Text] [Related]
11. A dual responsive nitric oxide / β-lapachone co-delivery platform for redox imbalance-enhanced tumor therapy.
Yang HZ; Chen JJ; Zhang L; Tian XL; Wang R; Pu L; Yu XQ; Zhang J
Eur J Pharm Biopharm; 2024 Jun; ():114348. PubMed ID: 38844097
[TBL] [Abstract][Full Text] [Related]
12. Arginase Inhibition Restores Peroxynitrite-Induced Endothelial Dysfunction via L-Arginine-Dependent Endothelial Nitric Oxide Synthase Phosphorylation.
Nguyen MC; Park JT; Jeon YG; Jeon BH; Hoe KL; Kim YM; Lim HK; Ryoo S
Yonsei Med J; 2016 Nov; 57(6):1329-38. PubMed ID: 27593859
[TBL] [Abstract][Full Text] [Related]
13. Increased photodynamic therapy sensitization in tumors using a nitric oxide-based nanoplatform with ATP-production blocking capability.
Xiang Q; Qiao B; Luo Y; Cao J; Fan K; Hu X; Hao L; Cao Y; Zhang Q; Wang Z
Theranostics; 2021; 11(4):1953-1969. PubMed ID: 33408791
[TBL] [Abstract][Full Text] [Related]
14. S-nitrosothiols loaded mini-sized Au@silica nanorod elicits collagen depletion and mitochondrial damage in solid tumor treatment.
Liu P; Wang Y; Liu Y; Tan F; Li J; Li N
Theranostics; 2020; 10(15):6774-6789. PubMed ID: 32550903
[TBL] [Abstract][Full Text] [Related]
15. A novel nitric oxide-based anticancer therapeutics by macrophage-targeted poly(l-arginine)-based nanoparticles.
Kudo S; Nagasaki Y
J Control Release; 2015 Nov; 217():256-62. PubMed ID: 26386436
[TBL] [Abstract][Full Text] [Related]
16. Small interfering RNA for cancer treatment: overcoming hurdles in delivery.
Charbe NB; Amnerkar ND; Ramesh B; Tambuwala MM; Bakshi HA; Aljabali AAA; Khadse SC; Satheeshkumar R; Satija S; Metha M; Chellappan DK; Shrivastava G; Gupta G; Negi P; Dua K; Zacconi FC
Acta Pharm Sin B; 2020 Nov; 10(11):2075-2109. PubMed ID: 33304780
[TBL] [Abstract][Full Text] [Related]
17. Modulation of peroxynitrite produced via mitochondrial nitric oxide synthesis during Ca
Gerdes HJ; Yang M; Heisner JS; Camara AKS; Stowe DF
Biochim Biophys Acta Bioenerg; 2020 Dec; 1861(12):148290. PubMed ID: 32828729
[TBL] [Abstract][Full Text] [Related]
18. Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment.
Zhang M; Hu W; Cai C; Wu Y; Li J; Dong S
Mater Today Bio; 2022 Mar; 14():100223. PubMed ID: 35243298
[TBL] [Abstract][Full Text] [Related]
19. Multiple Functions Integrated inside a Single Molecule for Amplification of Photodynamic Therapy Activity.
Shi X; Zhan Q; Li Y; Zhou L; Wei S
Mol Pharm; 2020 Jan; 17(1):190-201. PubMed ID: 31804837
[TBL] [Abstract][Full Text] [Related]
20. Fabrication of doxorubicin conjugated methoxy poly(ethylene glycol)-block-poly(ε-caprolactone) nanoparticles and study on their
Shen H; Liu Q; Liu D; Yu S; Wang X; Yang M
J Biomater Sci Polym Ed; 2021 Sep; 32(13):1703-1717. PubMed ID: 34075850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
